Recent developments with Esperion Therapeutics Inc (ESPR) have led to the company’s beta value being reach 1.03 cents.
Esperion Therapeutics Inc (NASDAQ: ESPR) on Friday, soared 7.83% from the previous trading day, before settling in for the closing price of $2.17. Within the